Kite Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Kite Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $42.41 per share as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2017-08-08
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $42.41.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $41.14.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $40.03.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $38.92.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2017-06-30 | $42.41 10-Q · filed 2017-08-08 |
| 2017-03-31 | $41.14 10-Q · filed 2017-05-08 |
| 2016-12-31 | $40.03 10-Q · filed 2017-08-08 |
| 2016-09-30 | $38.92 10-Q · filed 2016-11-09 |
| 2016-06-30 | $37.53 10-Q · filed 2016-08-08 |
| 2016-03-31 | $36.62 10-Q · filed 2016-05-09 |
| 2015-12-31 | $34.18 10-K · filed 2017-02-28 |
| 2015-09-30 | $28.74 10-Q · filed 2015-11-12 |
| 2015-06-30 | $21.15 10-Q · filed 2015-08-10 |
| 2015-03-31 | $21.15 10-Q · filed 2015-05-15 |
| 2014-12-31 | $14.01 10-K · filed 2016-02-29 |
| 2014-09-30 | $3.86 10-Q · filed 2014-11-14 |
| 2014-06-30 | $3.63 10-Q · filed 2014-08-14 |
| 2013-12-31 | $0.63 10-K · filed 2015-03-26 |